These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 17554147)
1. Growth hormone treatment during hemodialysis in a randomized trial improves nutrition, quality of life, and cardiovascular risk. Feldt-Rasmussen B; Lange M; Sulowicz W; Gafter U; Lai KN; Wiedemann J; Christiansen JS; El Nahas M; J Am Soc Nephrol; 2007 Jul; 18(7):2161-71. PubMed ID: 17554147 [TBL] [Abstract][Full Text] [Related]
2. OPPORTUNITY™: a large-scale randomized clinical trial of growth hormone in hemodialysis patients. Kopple JD; Cheung AK; Christiansen JS; Djurhuus CB; El Nahas M; Feldt-Rasmussen B; Mitch WE; Wanner C; Göthberg M; Ikizler TA Nephrol Dial Transplant; 2011 Dec; 26(12):4095-103. PubMed ID: 21750157 [TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD). Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776 [TBL] [Abstract][Full Text] [Related]
4. Effects of peridialytic oral supplements on nutritional status and quality of life in chronic hemodialysis patients. Scott MK; Shah NA; Vilay AM; Thomas J; Kraus MA; Mueller BA J Ren Nutr; 2009 Mar; 19(2):145-52. PubMed ID: 19218041 [TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of growth hormone in adult hemodialysis patients: results from a randomized controlled trial. Kober L; Rustom R; Wiedmann J; Kappelgaard AM; El Nahas M; Feldt-Rasmussen B Nephron Clin Pract; 2010; 115(3):c213-26. PubMed ID: 20413999 [TBL] [Abstract][Full Text] [Related]
7. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis. Schnabel D; Grasemann C; Staab D; Wollmann H; Ratjen F; Pediatrics; 2007 Jun; 119(6):e1230-8. PubMed ID: 17545356 [TBL] [Abstract][Full Text] [Related]
9. Minutes to recovery after a hemodialysis session: a simple health-related quality of life question that is reliable, valid, and sensitive to change. Lindsay RM; Heidenheim PA; Nesrallah G; Garg AX; Suri R; Clin J Am Soc Nephrol; 2006 Sep; 1(5):952-9. PubMed ID: 17699312 [TBL] [Abstract][Full Text] [Related]
10. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia. Li H; Wang SX Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498 [TBL] [Abstract][Full Text] [Related]
11. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. de Mutsert R; Grootendorst DC; Indemans F; Boeschoten EW; Krediet RT; Dekker FW; J Ren Nutr; 2009 Mar; 19(2):127-35. PubMed ID: 19218039 [TBL] [Abstract][Full Text] [Related]
12. Nutritional status evaluation and survival in haemodialysis patients in one centre from Romania. Segall L; Mardare NG; Ungureanu S; Busuioc M; Nistor I; Enache R; Marian S; Covic A Nephrol Dial Transplant; 2009 Aug; 24(8):2536-40. PubMed ID: 19297358 [TBL] [Abstract][Full Text] [Related]
13. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial. Pellicano R; Polkinghorne KR; Kerr PG Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807 [TBL] [Abstract][Full Text] [Related]
14. Use of physiological doses of human growth hormone in haematological patients receiving intensive chemotherapy promotes haematopoietic recovery: a double-blind randomized, placebo-controlled study. Sirohi B; Powles R; Morgan G; Treleaven J; Kulkarni S; Horton C; Saso R; Rolfe D; Cook G; Shaw C; Wass J Bone Marrow Transplant; 2007 Jan; 39(2):115-20. PubMed ID: 17143302 [TBL] [Abstract][Full Text] [Related]
15. Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis patients: a 2-year multicenter, prospective, randomized study. Cano NJ; Fouque D; Roth H; Aparicio M; Azar R; Canaud B; Chauveau P; Combe C; Laville M; Leverve XM; J Am Soc Nephrol; 2007 Sep; 18(9):2583-91. PubMed ID: 17656473 [TBL] [Abstract][Full Text] [Related]
16. Improving albumin levels among hemodialysis patients: a community-based randomized controlled trial. Leon JB; Albert JM; Gilchrist G; Kushner I; Lerner E; Mach S; Majerle A; Porter D; Ricanati E; Sperry L; Sullivan C; Zimmerer J; Sehgal AR Am J Kidney Dis; 2006 Jul; 48(1):28-36. PubMed ID: 16797384 [TBL] [Abstract][Full Text] [Related]
17. Long-term oral sodium bicarbonate supplementation does not improve serum albumin levels in hemodialysis patients. Bossola M; Giungi S; Tazza L; Luciani G Nephron Clin Pract; 2007; 106(1):c51-6. PubMed ID: 17409769 [TBL] [Abstract][Full Text] [Related]
18. A cohort study of subjective global assessment and mortality in Taiwanese hemodialysis patients. Yang FL; Lee RP; Wang CH; Fang TC; Hsu BG Ren Fail; 2007; 29(8):997-1001. PubMed ID: 18067047 [TBL] [Abstract][Full Text] [Related]
19. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis. Heinz J; Kropf S; Luley C; Dierkes J Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080 [TBL] [Abstract][Full Text] [Related]